S&P Global (NYSE: SPGI) today announced an agreement with a group led by majority investor Motive Partners, a private ...
New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell ...
Connections: Sports Edition is a New York Times word game about finding common sports threads between words. How to solve the ...
Abstract: Dynamic environments pose great challenges for expensive optimization problems, as the objective functions of these problems change over time and thus require remarkable computational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results